TY  - CONF

T1  - Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL – MCRPC): A Movember funded multicenter, randomized, controlled phase III study.

JO  - Journal of Clinical Oncology

PY  - 2016/05/20

AU  - Saad F

AU  - Kenfield SA

AU  - Chan JM

AU  - Hart NH

AU  - Courneya KS

AU  - Catto J

AU  - Finn SP

AU  - Greenwood R

AU  - Hughes DC

AU  - Mucci LA

AU  - Plymate SR et al

ED  - 

DO  - DOI: 10.1200/jco.2016.34.15_suppl.tps5092

PB  - American Society of Clinical Oncology (ASCO)

VL  - 34

IS  - 15_suppl

SP  - TPS5092

EP  - TPS5092

Y2  - 2024/10/23

ER  -